Статті в журналах з теми "Drug interactions Prevention"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Drug interactions Prevention".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Liekweg, A., and A. Hinnerkort. "311 Identification and prevention of drug-drug interactions." European Journal of Cancer Supplements 7, no. 2 (September 2009): 76. http://dx.doi.org/10.1016/s1359-6349(09)70264-2.
Повний текст джерелаWittkowsky, Ann K. "Workshop: Warfarin drug interactions: Detection, prediction, prevention." Journal of Thrombosis and Thrombolysis 2, no. 4 (March 1996): 295–99. http://dx.doi.org/10.1007/bf01061915.
Повний текст джерелаCavuto, N. J. "Pharmacies and prevention of potentially fatal drug interactions." JAMA: The Journal of the American Medical Association 275, no. 14 (April 10, 1996): 1086–87. http://dx.doi.org/10.1001/jama.275.14.1086.
Повний текст джерелаCavuto, Nicholas John. "Pharmacies and Prevention of Potentially Fatal Drug Interactions." JAMA: The Journal of the American Medical Association 275, no. 14 (April 10, 1996): 1086. http://dx.doi.org/10.1001/jama.1996.03530380028022.
Повний текст джерелаAliot, Etienne, and Josep Brugada. "Drug–Device Interactions." European Cardiology Review 6, no. 2 Supplement (2010): 8. http://dx.doi.org/10.15420/ecr.2010.6.2suppl.8.
Повний текст джерелаRIAZ, MUHAMMAD KASHIF. "POTENTIAL DRUG-DRUG INTERACTIONS AND STRATEGIES FOR THEIR DETECTION AND PREVENTION." FARMACIA 67, no. 4 (July 10, 2019): 572–79. http://dx.doi.org/10.31925/farmacia.2019.4.3.
Повний текст джерелаJyotsna, M., and Y. Hemalatha. "Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)." Indian Journal of Cardiovascular Disease in Women WINCARS 5, no. 03 (September 2020): 216–22. http://dx.doi.org/10.1055/s-0040-1716786.
Повний текст джерелаNesar, Shagufta, Muhammad Harris Shoaib, Kiran Rafiq, Muhammad Azhar Mughal, Tayyaba Mumtaz, Ishrat Younus, and Arfa Akram. "Medication errors with influencing factors of polypharmacy among elderly patients using Calcium Chanel Blockers." International Journal of Endorsing Health Science Research (IJEHSR) 10, no. 2 (June 1, 2022): 144–49. http://dx.doi.org/10.29052/ijehsr.v10.i2.2022.144-149.
Повний текст джерелаGulick, Roy M., and Charles Flexner. "Long-Acting HIV Drugs for Treatment and Prevention." Annual Review of Medicine 70, no. 1 (January 27, 2019): 137–50. http://dx.doi.org/10.1146/annurev-med-041217-013717.
Повний текст джерелаBaumann, P. "Drug interactions in the treatment of Bipolar disorder." European Psychiatry 26, S2 (March 2011): 2028. http://dx.doi.org/10.1016/s0924-9338(11)73731-2.
Повний текст джерелаAlderman, Christopher P. "Patient-Oriented Strategies for the Prevention of Drug Interactions." Drug Safety 22, no. 2 (2000): 103–9. http://dx.doi.org/10.2165/00002018-200022020-00003.
Повний текст джерелаLeape, Lucian L. "Pharmacies and Prevention of Potentially Fatal Drug Interactions-Reply." JAMA: The Journal of the American Medical Association 275, no. 14 (April 10, 1996): 1086. http://dx.doi.org/10.1001/jama.1996.03530380028023.
Повний текст джерелаPinson, G. Michelle, Jennifer W. Beall, and Jeffrey A. Kyle. "A Review of Warfarin Dosing With Concurrent Acetaminophen Therapy." Journal of Pharmacy Practice 26, no. 5 (June 3, 2013): 518–21. http://dx.doi.org/10.1177/0897190013488802.
Повний текст джерелаWoroń, Jarosław, Barbara Lorkowska-Zawicka, Elżbieta Dobrowolska, and Wojciech Serednicki. "Practical aspects of drugs interaction in pharmacotherapy in otolaryngology, ie the 7 deadly sins of pharmacological treatment in otolaryngology." Otolaryngologia Polska 70, no. 4 (May 24, 2016): 1–9. http://dx.doi.org/10.5604/00306657.1205273.
Повний текст джерелаAhmed, Shahela, Saquiba Yesmine, Mizanur Rahman, and Masum Shahriar. "Assessment of Interactions of Drugs Prescribed for Pediatric Patients in Bangladesh." Bangladesh Pharmaceutical Journal 24, no. 2 (July 10, 2021): 91–98. http://dx.doi.org/10.3329/bpj.v24i2.54706.
Повний текст джерелаSantos-Oliveira, Ralph, Sheila W. Smith, and Ana Maria A. Carneiro-Leão. "Radiopharmaceuticals drug interactions: a critical review." Anais da Academia Brasileira de Ciências 80, no. 4 (December 2008): 665–75. http://dx.doi.org/10.1590/s0001-37652008000400008.
Повний текст джерелаSzkutnik-Fiedler, Danuta. "Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies." Pharmaceutics 12, no. 12 (December 3, 2020): 1180. http://dx.doi.org/10.3390/pharmaceutics12121180.
Повний текст джерелаCalcagno, Anna, In-Wha Kim, Chung-Pu Wu, Suneet Shukla, and Suresh Ambudkar. "ABC Drug Transporters as Molecular Targets for the Prevention of Multidrug Resistance and Drug-Drug Interactions." Current Drug Delivery 4, no. 4 (October 1, 2007): 324–33. http://dx.doi.org/10.2174/156720107782151241.
Повний текст джерелаFerri, Nicola, Elisa Colombo, Marco Tenconi, Ludovico Baldessin, and Alberto Corsini. "Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice." Pharmaceutics 14, no. 6 (May 24, 2022): 1120. http://dx.doi.org/10.3390/pharmaceutics14061120.
Повний текст джерелаMcCabe, Beverly J. "Prevention of food-drug interactions with special emphasis on older adults." Current Opinion in Clinical Nutrition and Metabolic Care 7, no. 1 (January 2004): 21–26. http://dx.doi.org/10.1097/00075197-200401000-00005.
Повний текст джерелаAlburyhi, Mahmoud M., Abdalwali A. Saif, and Randa M. Saif. "PREFORMULATION STUDY OF CEFTRIAXONE AND CIPROFLOXACIN FOR LIPID BASED DRUG DELIVERY SYSTEMS." Electronic Journal of University of Aden for Basic and Applied Sciences 3, no. 4 (December 31, 2022): 339–50. http://dx.doi.org/10.47372/ejua-ba.2022.4.204.
Повний текст джерелаArya, Sagar S., Nada K. Morsy, Deema K. Islayem, Sarah A. Alkhatib, Charalampos Pitsalidis, and Anna-Maria Pappa. "Bacterial Membrane Mimetics: From Biosensing to Disease Prevention and Treatment." Biosensors 13, no. 2 (January 26, 2023): 189. http://dx.doi.org/10.3390/bios13020189.
Повний текст джерелаAuxtero, Maria D., Susana Chalante, Mário R. Abade, Rui Jorge, and Ana I. Fernandes. "Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction." Pharmaceutics 13, no. 1 (January 19, 2021): 124. http://dx.doi.org/10.3390/pharmaceutics13010124.
Повний текст джерелаZhou, Bo, Xian Zhao, Jing Lu, Zuntao Sun, Min Liu, Yilu Zhou, Rongzhi Liu, and Yihua Wang. "Relating Substructures and Side Effects of Drugs with Chemical-chemical Interactions." Combinatorial Chemistry & High Throughput Screening 23, no. 4 (May 19, 2020): 285–94. http://dx.doi.org/10.2174/1386207322666190702102752.
Повний текст джерелаKulikova, M. I., O. D. Ostroumova, and A. G. Komarova. "Drug-induced atrioventricular blockages." Medical alphabet 1, no. 19 (November 2, 2020): 56–64. http://dx.doi.org/10.33667/2078-5631-2020-19-56-64.
Повний текст джерелаYoung, Isabella C., and Soumya Rahima Benhabbour. "Multipurpose Prevention Technologies: Oral, Parenteral, and Vaginal Dosage Forms for Prevention of HIV/STIs and Unplanned Pregnancy." Polymers 13, no. 15 (July 26, 2021): 2450. http://dx.doi.org/10.3390/polym13152450.
Повний текст джерелаKlein, Hugh, and Judith A. Levy. "Shooting Gallery Users and HIV Risk." Journal of Drug Issues 33, no. 3 (July 2003): 751–68. http://dx.doi.org/10.1177/002204260303300312.
Повний текст джерелаBakulin, I. G., and M. Yu Serkova. "Medicinal-microbial interactions and ways of correcting iatrogenic intestinal dysbiosis." Experimental and Clinical Gastroenterology, no. 11 (January 23, 2023): 26–35. http://dx.doi.org/10.31146/1682-8658-ecg-207-11-26-35.
Повний текст джерелаFigueroa-Romero, Antia, Clara Pons-Duran, and Raquel Gonzalez. "Drugs for Intermittent Preventive Treatment of Malaria in Pregnancy: Current Knowledge and Way Forward." Tropical Medicine and Infectious Disease 7, no. 8 (July 28, 2022): 152. http://dx.doi.org/10.3390/tropicalmed7080152.
Повний текст джерелаSaverno, K., and DC Malone. "PHP92 EVALUATION OF A WIRELESS HANDHELD MEDICATION MANAGEMENT PROGRAM IN THE PREVENTION OF DRUG-DRUG INTERACTIONS." Value in Health 12, no. 3 (May 2009): A96. http://dx.doi.org/10.1016/s1098-3015(10)73541-5.
Повний текст джерелаSychev, I. N., L. V. Fedina, D. A. Gabrielyan, T. D. Rastvorova, E. V. Strigunkova, K. B. Mirzayev, and D. A. Sychev. "Anticoagulant therapy with direct oral anticoagulants in the context of polypragmasy: a course to safety." Meditsinskiy sovet = Medical Council, no. 17 (October 12, 2022): 52–64. http://dx.doi.org/10.21518/2079-701x-2022-16-17-52-64.
Повний текст джерелаLuscher, T. F., and J. Steffel. "Vitamin K antagonists." Hämostaseologie 32, no. 04 (2012): 249–57. http://dx.doi.org/10.5482/ha-12050008.
Повний текст джерелаRinner, Christoph, Wilfried Grossmann, Simone Katja Sauter, Michael Wolzt, and Walter Gall. "Effects of Shared Electronic Health Record Systems on Drug-Drug Interaction and Duplication Warning Detection." BioMed Research International 2015 (2015): 1–13. http://dx.doi.org/10.1155/2015/380497.
Повний текст джерелаYatskova, G. Yu, N. M. Maksymovych, and O. N. Zaliska. "Directions of optimization of information providing of pharmaceutical prophylaxis care for arterial hypertension." Farmatsevtychnyi zhurnal, no. 1 (March 18, 2019): 31–42. http://dx.doi.org/10.32352/0367-3057.1.19.03.
Повний текст джерелаPerzborn, E. "Factor Xa inhibitors." Hämostaseologie 29, no. 03 (2009): 260–67. http://dx.doi.org/10.1055/s-0037-1617033.
Повний текст джерелаDyadyk, A. I., T. E. Kugler, Y. V. Suliman, S. R. Zborovskyy, and I. I. Zdykhovskaya. "STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT." Russian Archives of Internal Medicine 8, no. 4 (August 12, 2018): 266–76. http://dx.doi.org/10.20514/2226-6704-2018-8-4-266-276.
Повний текст джерелаAyaz, Zainab, Bibi Zainab, Umer Rashid, Noura M. Darwish, Mansour K. Gatasheh, and Arshad Mehmood Abbasi. "In Silico Screening of Synthetic and Natural Compounds to Inhibit the Binding Capacity of Heavy Metal Compounds against EGFR Protein of Lung Cancer." BioMed Research International 2022 (May 14, 2022): 1–12. http://dx.doi.org/10.1155/2022/2941962.
Повний текст джерелаBraun, Barry. "Optimizing the Exercise Drug for Metabolic Rehabilitation." Kinesiology Review 4, no. 1 (February 2015): 107–12. http://dx.doi.org/10.1123/kr.2014-0084.
Повний текст джерелаBaracaldo-Santamaría, Daniela, Santiago Pabón-Londoño, and Luis Carlos Rojas-Rodriguez. "Drug safety of frequently used drugs and substances for self-medication in COVID-19." Therapeutic Advances in Drug Safety 13 (January 2022): 204209862210941. http://dx.doi.org/10.1177/20420986221094141.
Повний текст джерелаPAVANELLO, Larissa, Fátima G. FARHAT, Rafaela P. CARVALHO, and Hellen T. GREGÓRIO. "Clinically relevant drug interactions involving antimicrobials in a general hospital: a cross-sectional study." Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde 12, no. 2 (June 30, 2021): 573. http://dx.doi.org/10.30968/rbfhss.2021.122.0573.
Повний текст джерелаPagno, Andressa Rodrigues, Carolina Baldissera Gross, Daiana Meggiolaro Gewehr, Christiane de Fátima Colet, and Evelise Moraes Berlezi. "Drug therapy, potential interactions and iatrogenesis as factors related to frailty in the elderly." Revista Brasileira de Geriatria e Gerontologia 21, no. 5 (October 2018): 588–96. http://dx.doi.org/10.1590/1981-22562018021.180085.
Повний текст джерелаZhuravleva, M. V., B. K. Romanov, G. I. Gorodetskaya, O. V. Muslimova, V. S. Krysanova, and E. Yu Demchenkova. "Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance." Safety and Risk of Pharmacotherapy 7, no. 3 (September 17, 2019): 109–19. http://dx.doi.org/10.30895/2312-7821-2019-7-3-109-119.
Повний текст джерелаArul Balasubramanian, Rinson Reji, Rosmy Jose, Sarika Sasidharan, and Kothai Ramalingam. "Drug utilization review of corticosteroids in a tertiary care hospital of Salem District, Tamilnadu, India." International Journal of Research in Pharmaceutical Sciences 10, no. 3 (July 20, 2019): 2246–49. http://dx.doi.org/10.26452/ijrps.v10i3.1459.
Повний текст джерелаZakrzewski-Jakubiak, Hubert, Julie Doan, Pamela Lamoureux, Dharmender Singh, Jacques Turgeon, and Cara Tannenbaum. "Detection and Prevention of Drug–Drug Interactions in the Hospitalized Elderly: Utility of New Cytochrome P450–Based Software." American Journal of Geriatric Pharmacotherapy 9, no. 6 (December 2011): 461–70. http://dx.doi.org/10.1016/j.amjopharm.2011.09.006.
Повний текст джерелаWoroń, Jarosław, Wojciech Leppert, Radosław Tymiński, Michał Graczyk, Halina Kutaj–Wąsikowska, Wojciech Serednicki, and Jerzy Wordliczek. "Undesirable effects of polypharmacotherapy in patients with cancer-associated pain treated under palliative care." BÓL 18, no. 4 (December 31, 2017): 11–19. http://dx.doi.org/10.5604/01.3001.0012.0655.
Повний текст джерелаSchloer, Sebastian, Jonas Goretzko, Stephan Pleschka, Stephan Ludwig, and Ursula Rescher. "Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection." Viruses 12, no. 7 (June 29, 2020): 703. http://dx.doi.org/10.3390/v12070703.
Повний текст джерелаSharma, Munish, Sabarina Ramanathan, and Koroush Khalighi. "Development of New Deep Venous Thrombosis While on Apixaban." Case Reports in Cardiology 2017 (2017): 1–3. http://dx.doi.org/10.1155/2017/2842935.
Повний текст джерелаDushenkov, Anna, Julie Kalabalik, Antonia Carbone, and Paiboon Jungsuwadee. "Drug interactions with aprepitant or fosaprepitant: Review of literature and implications for clinical practice." Journal of Oncology Pharmacy Practice 23, no. 4 (February 25, 2016): 296–308. http://dx.doi.org/10.1177/1078155216631408.
Повний текст джерелаKyselova, Zuzana. "Toxicological aspects of the use of phenolic compounds in disease prevention." Interdisciplinary Toxicology 4, no. 4 (December 1, 2011): 173–83. http://dx.doi.org/10.2478/v10102-011-0027-5.
Повний текст джерелаEdwards, J. Guy. "Newer v. older antidepressants in long-term pharmacotherapy: Revisiting… Prevention of relapse and recurrence of depression." Advances in Psychiatric Treatment 11, no. 3 (May 2005): 184–94. http://dx.doi.org/10.1192/apt.11.3.184.
Повний текст джерела